What do systematic reviews say?

Summary of findings: 5 mg/day vs placebo

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

It is very uncertain whether summary of findings: 5 mg/day changes headache ( compared with injection with corticosteroid and anaesthetic (very low certainty).

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  RR 31.003 [1.96, 490.31]
  1 study · 48 participants
  Very low

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

It is very uncertain whether summary of findings: 5 mg/day changes injection site pain ( compared with injection with corticosteroid and anaesthetic (very low certainty).

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  RR 0.11 [0.01, 1.96]
  1 study · 48 participants
  Very low

Summary of findings: 5 mg/day vs placebo

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 20 participants
  Low

Summary of findings: 5 mg/day vs placebo

It is very uncertain whether summary of findings: 5 mg/day changes symptom free ( compared with placebo (very low certainty).

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  RR 1.91 [1.04, 3.5]
  1 study · 20 participants
  Very low

Summary of findings: 5 mg/day vs placebo

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs placebo

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs placebo

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation

Summary of findings: 1.25 mg/day plus rehabilitation showed no clear difference in headache ( compared with placebo plus rehabilitation (low certainty).

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  RR 1.73 [0.92, 3.24]
  1 study · 53 participants
  Low

Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation

Summary of findings: 1.25 mg/day plus rehabilitation showed no clear difference in rash ( compared with placebo plus rehabilitation (low certainty).

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  RR 3.12 [0.35, 28.06]
  1 study · 53 participants
  Low

Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation

Summary of findings: 1.25 mg/day plus rehabilitation showed no clear difference in symptom free with activities of daily living (patient rated) ( compared with placebo plus rehabilitation (low certainty).

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  RR 1.92 [0.92, 4.1]
  1 study · 57 participants
  Low

Summary of findings table ‐ Progestogens vs GnRH antagonists

• Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 534 participants
  GRADE not reported